160 related articles for article (PubMed ID: 21968105)
41. Human cytomegalovirus gene expression in long-term infected glioma stem cells.
Fiallos E; Judkins J; Matlaf L; Prichard M; Dittmer D; Cobbs C; Soroceanu L
PLoS One; 2014; 9(12):e116178. PubMed ID: 25549333
[TBL] [Abstract][Full Text] [Related]
42. Insulin-like growth factor-I receptor - a potential therapeutic target in medulloblastomas.
Reiss K
Expert Opin Ther Targets; 2002 Oct; 6(5):539-44. PubMed ID: 12387677
[TBL] [Abstract][Full Text] [Related]
43. Human cytomegalovirus infection contributes to glioma disease progression via upregulating endocan expression.
Xing Y; Wang Y; Wang S; Wang X; Fan D; Zhou D; An J
Transl Res; 2016 Nov; 177():113-126. PubMed ID: 27474433
[TBL] [Abstract][Full Text] [Related]
44. Investigation of human brain tumors for the presence of polyomavirus genome sequences by two independent laboratories.
Rollison DE; Utaipat U; Ryschkewitsch C; Hou J; Goldthwaite P; Daniel R; Helzlsouer KJ; Burger PC; Shah KV; Major EO
Int J Cancer; 2005 Feb; 113(5):769-74. PubMed ID: 15499616
[TBL] [Abstract][Full Text] [Related]
45. Cytomegalovirus and glioblastoma: a review of evidence for their association and indications for testing and treatment.
Solomon IH; Ramkissoon SH; Milner DA; Folkerth RD
J Neuropathol Exp Neurol; 2014 Nov; 73(11):994-8. PubMed ID: 25289896
[TBL] [Abstract][Full Text] [Related]
46. Treatment of medulloblastoma with a modified measles virus.
Studebaker AW; Kreofsky CR; Pierson CR; Russell SJ; Galanis E; Raffel C
Neuro Oncol; 2010 Oct; 12(10):1034-42. PubMed ID: 20494960
[TBL] [Abstract][Full Text] [Related]
47. Detection of human cytomegalovirus in different histological types of gliomas.
Scheurer ME; Bondy ML; Aldape KD; Albrecht T; El-Zein R
Acta Neuropathol; 2008 Jul; 116(1):79-86. PubMed ID: 18351367
[TBL] [Abstract][Full Text] [Related]
48. Lack of human cytomegalovirus expression in single cells from glioblastoma tumors and cell lines.
Johnson TS; Abrams ZB; Mo X; Zhang Y; Huang K
J Neurovirol; 2017 Oct; 23(5):671-678. PubMed ID: 28695489
[TBL] [Abstract][Full Text] [Related]
49. Consensus on the role of human cytomegalovirus in glioblastoma.
Dziurzynski K; Chang SM; Heimberger AB; Kalejta RF; McGregor Dallas SR; Smit M; Soroceanu L; Cobbs CS;
Neuro Oncol; 2012 Mar; 14(3):246-55. PubMed ID: 22319219
[TBL] [Abstract][Full Text] [Related]
50. New research directions in medulloblastoma.
Grill J; Dufour C; Guerrini-Rousseau L; Ayrault O
Neurochirurgie; 2021 Feb; 67(1):87-89. PubMed ID: 30904166
[TBL] [Abstract][Full Text] [Related]
51. Genomic and transcriptomic analyses match medulloblastoma mouse models to their human counterparts.
Pöschl J; Stark S; Neumann P; Gröbner S; Kawauchi D; Jones DT; Northcott PA; Lichter P; Pfister SM; Kool M; Schüller U
Acta Neuropathol; 2014 Jul; 128(1):123-36. PubMed ID: 24871706
[TBL] [Abstract][Full Text] [Related]
52. Malignant gliomas in adults.
Meyer MA
N Engl J Med; 2008 Oct; 359(17):1850; author reply 1850. PubMed ID: 18946076
[No Abstract] [Full Text] [Related]
53. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.
Kool M; Koster J; Bunt J; Hasselt NE; Lakeman A; van Sluis P; Troost D; Meeteren NS; Caron HN; Cloos J; Mrsić A; Ylstra B; Grajkowska W; Hartmann W; Pietsch T; Ellison D; Clifford SC; Versteeg R
PLoS One; 2008 Aug; 3(8):e3088. PubMed ID: 18769486
[TBL] [Abstract][Full Text] [Related]
54. The therapy of infantile malignant brain tumors: current status?
Kalifa C; Grill J
J Neurooncol; 2005 Dec; 75(3):279-85. PubMed ID: 16195802
[TBL] [Abstract][Full Text] [Related]
55. The molecular genetics of medulloblastoma: an assessment of new therapeutic targets.
Carlotti CG; Smith C; Rutka JT
Neurosurg Rev; 2008 Oct; 31(4):359-68; discussion 368-9. PubMed ID: 18548301
[TBL] [Abstract][Full Text] [Related]
56. HDAC5 and HDAC9 in medulloblastoma: novel markers for risk stratification and role in tumor cell growth.
Milde T; Oehme I; Korshunov A; Kopp-Schneider A; Remke M; Northcott P; Deubzer HE; Lodrini M; Taylor MD; von Deimling A; Pfister S; Witt O
Clin Cancer Res; 2010 Jun; 16(12):3240-52. PubMed ID: 20413433
[TBL] [Abstract][Full Text] [Related]
57. Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas.
Künkele A; De Preter K; Heukamp L; Thor T; Pajtler KW; Hartmann W; Mittelbronn M; Grotzer MA; Deubzer HE; Speleman F; Schramm A; Eggert A; Schulte JH
Neuro Oncol; 2012 Jul; 14(7):859-69. PubMed ID: 22591662
[TBL] [Abstract][Full Text] [Related]
58. [Hypermethylation as a potential prognostic factor and a clue to a better understanding of the molecular pathogenesis of medulloblastoma--results of a genomewide methylation scan].
Frühwald MC; O'Dorisio MS; Smith L; Dai Z; Wright FA; Paulus W; Jürgens H; Plass C
Klin Padiatr; 2001; 213(4):197-203. PubMed ID: 11528554
[TBL] [Abstract][Full Text] [Related]
59. Management of and prognosis with medulloblastoma: therapy at a crossroads.
Packer RJ; Vezina G
Arch Neurol; 2008 Nov; 65(11):1419-24. PubMed ID: 19001159
[TBL] [Abstract][Full Text] [Related]
60. Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial.
Grundy RG; Wilne SH; Robinson KJ; Ironside JW; Cox T; Chong WK; Michalski A; Campbell RH; Bailey CC; Thorp N; Pizer B; Punt J; Walker DA; Ellison DW; Machin D;
Eur J Cancer; 2010 Jan; 46(1):120-33. PubMed ID: 19818598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
